influenza a (h1n1) 2009 vaccine

Influenza A (H1N1) 2009 vaccine is a monovalent vaccine developed in response to the 2009 H1N1 influenza pandemic. It is designed for active immunization against disease caused by the pandemic influenza A (H1N1) 2009 virus. The vaccine is produced using the A/California/7/2009 (H1N1)pdm strain and is available in both inactivated and live, attenuated formulations, with specific formulations prepared as purified surface antigen subunits or as live attenuated virus. The inactivated vaccines are administered intramuscularly and contain non-infectious particles, while the live attenuated version is administered intranasally. The vaccine operates as an immunotherapy, stimulating host immune responses to develop protective antibodies primarily against hemagglutinin and neuraminidase surface antigens of the influenza virus[1][3][4].

Other names

h1n1 vaccineh-1n1 vaccineh 1n1 vaccinepandemic h1n1 2009 vaccineswine flu vaccine (2009 pandemic)